pleural effusion

Types

 inflammatory pleural effusion

• neutrophilic pleural effusion
• eosinophilic pleural effusion
• lymphocytic pleural effusion
• histiocytic pleural effusion

 tumoral pleural effusion

Etiology

 drug-induced pleural effusion (drug-induced pleural exudate)

• lone non-eosinophilic pleural effusion
• lone eosinophilic pleural effusion
• pleural effusion associated with drug-induced pneumonitis
• drug-induced lupus erythematosus (DILE)
• drug-induced pleural thickening
  • irradiation
  • amiodarone
  • ergolines
  • chemotherapeutic agents (cyclophosphamid)
  • practolol
  • corticosteroids

 asbestos-associated fibrinous pleural effusion
 pulmonary edema
 pulmonary capillary leak syndrome

Books

 Pleural disease, 2nd edition. Bouros D. et al.

See also

 pleural anomalies
 pleural diseases

Open references

 Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: a combination panel-based approach with a brief review of the literature. Murugan P, Siddaraju N, Habeebullah S, Basu D. Indian J Pathol Microbiol. 2009 Apr-Jun;52(2):175-81. PMID: 19332905 (Free)

References

 Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations. Ikeda K, Tate G, Suzuki T, Kitamura T, Mitsuya T. Diagn Cytopathol. 2011 Jun;39(6):395-401. doi : 10.1002/dc.21398 PMID: 21574259

 The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Hasteh F, Lin GY, Weidner N, Michael CW. Cancer Cytopathol. 2010 Apr 25;118(2):90-6. doi : 10.1002/cncy.20071 PMID: 20209622

 Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions. Lee JS, Nam JH, Lee MC, Park CS, Juhng SW. Acta Cytol. 1996 Jul-Aug;40(4):631-6. PMID: 8693877

 Significance of epithelial membrane antigen in the work-up of problematic serous effusions. Singh HK, Silverman JF, Berns L, Haddad MG, Park HK. Diagn Cytopathol. 1995 Jul;13(1):3-7. PMID: 7587872

 Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions. Chen CJ, Chang SC, Tseng HH. Zhonghua Yi Xue Za Zhi (Taipei). 1994 Sep;54(3):149-55. PMID: 7954054

 Markers for metastatic adenocarcinoma in serous effusion specimens. Shield PW, Callan JJ, Devine PL. Diagn Cytopathol. 1994;11(3):237-45. PMID: 7532566